<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7242950\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="action, its immunomodulatory effect, which justifies its use in the" exact="chronic" post="treatment of rheumatoid arthritis and systemic lupus erythematosus, may"/>
  <result pre="effect, which justifies its use in the chronic treatment of" exact="rheumatoid arthritis" post="and systemic lupus erythematosus, may be of special interest"/>
  <result pre="which justifies its use in the chronic treatment of rheumatoid" exact="arthritis" post="and systemic lupus erythematosus, may be of special interest"/>
  <result pre="its use in the chronic treatment of rheumatoid arthritis and" exact="systemic" post="lupus erythematosus, may be of special interest in SARS-CoV2"/>
  <result pre="use in the chronic treatment of rheumatoid arthritis and systemic" exact="lupus erythematosus," post="may be of special interest in SARS-CoV2 infection, especially"/>
  <result pre="should be used with caution because they could prolong the" exact="infection" post="time by depressing the immune system,5, 7 the combined"/>
  <result pre="The first study of the use of chloroquine in coronavirus-19" exact="infection" post="was conducted in China and was published on 4th"/>
  <result pre="various antivirals on Vero E6 cells, which come from kidney" exact="epithelial" post="cells isolated from an African green monkey. To assess"/>
  <result pre="cells, which come from kidney epithelial cells isolated from an" exact="African" post="green monkey. To assess the effect, they measured EC50,"/>
  <result pre="Vero cells infection, while remdesivir was only effective with the" exact="infection" post="already established.8 The fact that the concentration with which"/>
  <result pre="pathogen, of 6.90Â Î¼M, was previously achieved in patients with" exact="rheumatoid arthritis" post="at doses of 500Â mg8 motivated the start of"/>
  <result pre="of 6.90Â Î¼M, was previously achieved in patients with rheumatoid" exact="arthritis" post="at doses of 500Â mg8 motivated the start of"/>
  <result pre="images, promote virus suppression and shorten the duration of the" exact="disease" post="without producing any serious adverse reaction.9 Given this evidence,"/>
  <result pre="virus. This study revealed that the EC50 of hydroxychloroquine was" exact="lower" post="than that of chloroquine, both in therapeutic and prophylactic"/>
  <result pre="to keep the calculated concentrations in blood and lungs relatively" exact="stable" post="throughout the treatment. These are the findings that precede"/>
  <result pre="disease; 16.2% and 1.2% of hospitalized patients remained in the" exact="infectious diseases" post="department and ICU, respectively, and only one 86-year-old patient"/>
  <result pre="only one 86-year-old patient who had been admitted with advanced" exact="pneumonia" post="died during the study. Similar to what happened in"/>
  <result pre="by a randomized clinical trial of 62 patients with mild" exact="pneumonia" post="(without hypoxia) due to SARS-CoV2, published on 30th March"/>
  <result pre="30th March in China, which found significant differences in the" exact="total" post="or partial resolution of pneumonia among the group treated"/>
  <result pre="in China, which found significant differences in the total or" exact="partial" post="resolution of pneumonia among the group treated with 400Â"/>
  <result pre="found significant differences in the total or partial resolution of" exact="pneumonia" post="among the group treated with 400Â mg/day of hydroxychloroquine"/>
  <result pre="30 patients with COVID-19 infection, found no significant difference in" exact="viral" post="load at 7 days of treatment, nor in the"/>
  <result pre="tomography or adverse reactions, which, for both groups, consisted of" exact="transient" post="diarrhoea and impaired liver function. It should be noted"/>
  <result pre="chloroquine and/or hydroxychloroquine are used at high doses in the" exact="acute" post="attack of malaria, Q fever and Whipple's disease12, 13,"/>
  <result pre="used at high doses in the acute attack of malaria," exact="Q fever" post="and Whipple's disease12, 13, 19 and, specifically on COVID-19"/>
  <result pre="of hydroxychloroquine overdose, a risk that we can face with" exact="short" post="regimens at high doses, could be actively prevented if"/>
  <result pre="intermittent electrocardiogram monitoring is used during treatment, a maintenance dose" exact="lower" post="than that of induction is applied to prevent its"/>
  <result pre="and recognized risk factor for the development of potentially fatal" exact="malignant" post="arrhythmias.21 Furthermore, QTc prolongation was independent of baseline values,"/>
  <result pre="is currently underway in more than 130,000 patients with COVID-19" exact="pneumonia" post="(ClinicalTrials.gov identifier: NCT04321278).23 The fact that, according to a"/>
  <result pre="of interests None declared. References References 1SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of chloroquine on" exact="viral" post="infections: an old drug against today's diseases?Lancet Infect. Dis.3200372272710.1016/S1473-3099(03)00806-514592603"/>
  <result pre="to expect for COVID-19?Int. J. Antimicrob. Agents202010593810.1016/j.ijantimicag.2020.10593832171740 4SahraeiZ.ShabaniM.ShokouhiS.SaffaeiA.Aminoquinolines against coronavirus" exact="disease" post="2019 (COVID-19): chloroquine or hydroxychloroquineInt. J. Antimicrob. Agents202010594510.1016/j.ijantimicag.2020.10594532194152 5YaoX.YeF.ZhangM.CuiC.HuangB.NiuP.In"/>
  <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis.202010.1093/cid/ciaa237 6FuY.ChengY.WuY.Understanding SARS-CoV-2-mediated"/>
  <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis.202010.1093/cid/ciaa237 6FuY.ChengY.WuY.Understanding SARS-CoV-2-mediated inflammatory"/>
  <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis.202010.1093/cid/ciaa237 6FuY.ChengY.WuY.Understanding SARS-CoV-2-mediated inflammatory responses:"/>
  <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends142020727310.5582/bst.2020.0104732074550 10General Office of National Health"/>
  <result pre="of National Health CommissionDiagnostic and treatment protocol for novel coronavirus" exact="pneumonia" post="(trial version 6)2020117Available from: http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm 11MarmorM.F.KellnerU.LaiT.Y.Y.MellesR.B.MielerW.F.LumF.Recommendations on screening for"/>
  <result pre="clinical trialmedRxiv72020202010.1101/2020.03.22.20040758 16ZhouF.YuT.DuR.FanG.LiuY.XiangJ.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
  <result pre="hydroxychloroquine donated to US despite lack of evidenceBMJ3682020m116610.1136/bmj.m116632205321 19Centers for" exact="Disease" post="Control and PreventionDiagnosis and management of Q fever2013 20ChicoR.M.ChandramohanD.Azithromycin"/>
  <result pre="Q fever2013 20ChicoR.M.ChandramohanD.Azithromycin plus chloroquine: combination therapy for protection against" exact="malaria" post="and sexually transmitted infections in pregnancyExpert Opin Drug Metab"/>
  <result pre="chloroquine: combination therapy for protection against malaria and sexually transmitted" exact="infections" post="in pregnancyExpert Opin Drug Metab Toxicol720111153116710.1517/17425255.2011.59850621736423 21ChorinE.DaiM.ShulmanE.WadhwainL.CohenR.B.BarbhaiyaC.The QT interval"/>
  <result pre="Drug Metab Toxicol720111153116710.1517/17425255.2011.59850621736423 21ChorinE.DaiM.ShulmanE.WadhwainL.CohenR.B.BarbhaiyaC.The QT interval in patients with SARS-CoV-2" exact="infection" post="treated with hydroxychloroquine/azithromycinmedRxiv212020202010.1101/2020.04.02.20047050 22Generalitat de CatalunyaNota Informativa Sobre lâ€™"/>
 </snippets>
</snippetsTree>
